Three Health Care Stocks That Could Revitalize Your Portfolio This November
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 04 2025
0mins
Should l Buy ACHC?
Source: Benzinga
Oversold Stocks Opportunity: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Alvotech SA Update: Alvotech's stock dropped 41% over the past month following an FDA Complete Response Letter regarding its AVT05 biosimilar application, with an RSI of 18.8 and a closing price of $5.03.
Acadia Healthcare Performance: Acadia Healthcare's stock fell 19% in the last month, with an RSI of 27.9, and it closed at $21.31 ahead of its third-quarter results announcement.
Akebia Therapeutics Decline: Akebia Therapeutics experienced a 33% drop in stock price over five days, with an RSI of 29.4, closing at $2.12 after reporting inducement grants.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACHC
Wall Street analysts forecast ACHC stock price to rise
11 Analyst Rating
5 Buy
5 Hold
1 Sell
Moderate Buy
Current: 16.415
Low
13.00
Averages
18.10
High
25.00
Current: 16.415
Low
13.00
Averages
18.10
High
25.00
About ACHC
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. It provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. Its comprehensive treatment centers specialize in providing medication-assisted treatment in an outpatient setting. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The facilities balance therapy activities with social, academic and other activities. It operates a network of 262 behavioral healthcare facilities with over 11,850 beds in 39 states and Puerto Rico.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
David Einhorn's Concerns on AI Overvaluation Impacting Stock Picks
- Investment Strategy Shift: David Einhorn invested tens of millions in Q4 2025 to increase stakes in Graphic Packaging and Capri Holdings by over 70%, reflecting his concerns about AI-driven market overvaluation and indicating a strategic pivot away from big tech.
- Stock Performance Volatility: Despite Graphic Packaging's shares dropping about 23% in Q4 2025 and over 44% for the year, Wall Street analysts remain optimistic, with an average price target suggesting more than 35% upside, indicating expectations for a rebound in the stock.
- Healthcare Investments: Einhorn more than doubled his position in Acadia Healthcare to over $58 million, despite a 43% plunge in Q4; however, analysts maintain a buy rating with a price target suggesting over 16% upside in the next 12 months, reflecting confidence in its recovery.
- Cautious on Tech Stocks: While expressing concerns about tech valuations, Einhorn established a $35 million stake in Global Payments, which fell 31% in 2025 but rebounded nearly 5% in 2026, with analysts' price targets implying over 25% upside, suggesting market optimism for its future performance.
See More
Acadia Healthcare Shares Surge on Investor Interest from David Einhorn
- Surge in Investor Interest: Hedge fund manager David Einhorn disclosed his recent purchases of Acadia Healthcare stock during a CNBC appearance, leading to a 15% surge in shares on Wednesday, indicating renewed market interest in the behavioral healthcare operator.
- Current Technical Analysis: Acadia's stock is trading 10.4% above its 20-day simple moving average but remains below its 100-day and 200-day SMAs, suggesting short-term strength but long-term challenges, with a 64.48% decline over the past year.
- Earnings Expectations and Analyst Outlook: Acadia is set to report earnings on February 25, with an EPS estimate of 4 cents and revenue forecast of $799.53 million, indicating growth potential despite challenges, and a P/E ratio of 11.8x suggesting a value opportunity.
- Analyst Rating Dynamics: The stock carries a “Buy” rating with an average price target of $35.37, although RBC Capital and Jefferies have lowered their targets to $17.00 and $15.00 respectively, reflecting mixed market sentiment regarding its future performance.
See More
Stock Price Movements of Various Companies
- Acadia Healthcare Stock Surge: Acadia Healthcare's stock rose 10% after investor David Einhorn announced his purchases, reflecting market optimism about the new management's ability to enhance performance, which could improve future profitability.
- Vertiv's Upbeat Guidance: Vertiv's stock jumped nearly 20% due to its optimistic guidance for 2026, with orders accelerating significantly in Q4, surpassing Wall Street expectations and indicating strong demand in the data center market.
- Unity Software's Downgrade: Unity Software's shares fell nearly 30% after issuing a first-quarter revenue outlook between $480 million and $490 million, below analysts' expectations of $492.1 million, raising concerns about its future growth prospects.
- Smurfit WestRock Order Improvement: Smurfit WestRock's stock soared over 10% after revealing improved product orders in late December, with expectations of reaching $7 billion in profits by 2030, highlighting its long-term growth potential.
See More
David Einhorn Bullish on Peloton After Dip
- Overreaction by Investors: David Einhorn purchased Peloton stock after its latest earnings report, asserting that investors overreacted to the company's disappointing holiday quarter results, which caused a 26% drop in share price on Thursday, while he believes new management and an improving balance sheet will drive recovery.
- Historical Price Comparison: Peloton's stock peaked above $170 during the pandemic but has since plummeted to under $5; Einhorn argues that the stock has been unfairly punished and anticipates improvements in cash flow through cost-cutting and debt refinancing in the near future.
- Acadia Healthcare Outlook: Einhorn is also optimistic about Acadia Healthcare, suggesting that the return of a former successful CEO could help revive the stock, which has fallen from $80 to $13 in recent years, with potential for it to rebound significantly in the coming years.
- View on Housing Market: Einhorn expressed a negative outlook on the housing market, citing a structural decline due to housing shortages, rising rates, and affordability challenges, while mentioning he has high-conviction short positions that he does not plan to disclose.
See More
Acadia Healthcare Shares Surge 12% Following Einhorn's Endorsement
- Stock Surge: Acadia Healthcare (ACHC) shares rose approximately 12% on Wednesday after hedge fund manager David Einhorn endorsed the company, indicating growing market confidence in its future prospects.
- Volume Spike: Nearly 6 million shares of Acadia (ACHC) have changed hands so far, significantly exceeding the 65-day average of 3.4 million shares, suggesting a notable increase in investor interest and potential for future growth.
- Historical Performance Review: Despite a more than 64% decline last year, this rally marks the second-largest intraday gain for 2026, reflecting market expectations for a rebound and potentially attracting more investor attention.
- Leadership Change: Since Debra Osteen took over as CEO in January 2023, Acadia (ACHC) has gained approximately 9% year-to-date, indicating that the new leadership may be steering the company towards a more positive trajectory.
See More
Acadia Healthcare to Release Q4 and Year-End 2025 Results
- Earnings Release Schedule: Acadia Healthcare announced it will release its Q4 and year-end 2025 results on February 25, 2026, before market open, reflecting the company's commitment to transparency and investor communication.
- Investor Conference Call: On the same day, Acadia will hold a conference call at 9:00 a.m. ET to engage with institutional investors and analysts, aiming to enhance market confidence.
- Network Coverage: As of September 30, 2025, Acadia operates 278 behavioral healthcare facilities across the U.S. and Puerto Rico, providing approximately 12,500 beds, showcasing its leadership in the industry.
- Employee and Patient Services: With around 25,500 employees serving over 82,000 patients daily, Acadia solidifies its position as the largest stand-alone behavioral healthcare company in the U.S.
See More
David Einhorn's Concerns on AI Overvaluation Impacting Stock Picks
- Investment Strategy Shift: David Einhorn invested tens of millions in Q4 2025 to increase stakes in Graphic Packaging and Capri Holdings by over 70%, reflecting his concerns about AI-driven market overvaluation and indicating a strategic pivot away from big tech.
- Stock Performance Volatility: Despite Graphic Packaging's shares dropping about 23% in Q4 2025 and over 44% for the year, Wall Street analysts remain optimistic, with an average price target suggesting more than 35% upside, indicating expectations for a rebound in the stock.
- Healthcare Investments: Einhorn more than doubled his position in Acadia Healthcare to over $58 million, despite a 43% plunge in Q4; however, analysts maintain a buy rating with a price target suggesting over 16% upside in the next 12 months, reflecting confidence in its recovery.
- Cautious on Tech Stocks: While expressing concerns about tech valuations, Einhorn established a $35 million stake in Global Payments, which fell 31% in 2025 but rebounded nearly 5% in 2026, with analysts' price targets implying over 25% upside, suggesting market optimism for its future performance.
See More
Acadia Healthcare Shares Surge on Investor Interest from David Einhorn
- Surge in Investor Interest: Hedge fund manager David Einhorn disclosed his recent purchases of Acadia Healthcare stock during a CNBC appearance, leading to a 15% surge in shares on Wednesday, indicating renewed market interest in the behavioral healthcare operator.
- Current Technical Analysis: Acadia's stock is trading 10.4% above its 20-day simple moving average but remains below its 100-day and 200-day SMAs, suggesting short-term strength but long-term challenges, with a 64.48% decline over the past year.
- Earnings Expectations and Analyst Outlook: Acadia is set to report earnings on February 25, with an EPS estimate of 4 cents and revenue forecast of $799.53 million, indicating growth potential despite challenges, and a P/E ratio of 11.8x suggesting a value opportunity.
- Analyst Rating Dynamics: The stock carries a “Buy” rating with an average price target of $35.37, although RBC Capital and Jefferies have lowered their targets to $17.00 and $15.00 respectively, reflecting mixed market sentiment regarding its future performance.
See More
Stock Price Movements of Various Companies
- Acadia Healthcare Stock Surge: Acadia Healthcare's stock rose 10% after investor David Einhorn announced his purchases, reflecting market optimism about the new management's ability to enhance performance, which could improve future profitability.
- Vertiv's Upbeat Guidance: Vertiv's stock jumped nearly 20% due to its optimistic guidance for 2026, with orders accelerating significantly in Q4, surpassing Wall Street expectations and indicating strong demand in the data center market.
- Unity Software's Downgrade: Unity Software's shares fell nearly 30% after issuing a first-quarter revenue outlook between $480 million and $490 million, below analysts' expectations of $492.1 million, raising concerns about its future growth prospects.
- Smurfit WestRock Order Improvement: Smurfit WestRock's stock soared over 10% after revealing improved product orders in late December, with expectations of reaching $7 billion in profits by 2030, highlighting its long-term growth potential.
See More
David Einhorn Bullish on Peloton After Dip
- Overreaction by Investors: David Einhorn purchased Peloton stock after its latest earnings report, asserting that investors overreacted to the company's disappointing holiday quarter results, which caused a 26% drop in share price on Thursday, while he believes new management and an improving balance sheet will drive recovery.
- Historical Price Comparison: Peloton's stock peaked above $170 during the pandemic but has since plummeted to under $5; Einhorn argues that the stock has been unfairly punished and anticipates improvements in cash flow through cost-cutting and debt refinancing in the near future.
- Acadia Healthcare Outlook: Einhorn is also optimistic about Acadia Healthcare, suggesting that the return of a former successful CEO could help revive the stock, which has fallen from $80 to $13 in recent years, with potential for it to rebound significantly in the coming years.
- View on Housing Market: Einhorn expressed a negative outlook on the housing market, citing a structural decline due to housing shortages, rising rates, and affordability challenges, while mentioning he has high-conviction short positions that he does not plan to disclose.
See More
Acadia Healthcare Shares Surge 12% Following Einhorn's Endorsement
- Stock Surge: Acadia Healthcare (ACHC) shares rose approximately 12% on Wednesday after hedge fund manager David Einhorn endorsed the company, indicating growing market confidence in its future prospects.
- Volume Spike: Nearly 6 million shares of Acadia (ACHC) have changed hands so far, significantly exceeding the 65-day average of 3.4 million shares, suggesting a notable increase in investor interest and potential for future growth.
- Historical Performance Review: Despite a more than 64% decline last year, this rally marks the second-largest intraday gain for 2026, reflecting market expectations for a rebound and potentially attracting more investor attention.
- Leadership Change: Since Debra Osteen took over as CEO in January 2023, Acadia (ACHC) has gained approximately 9% year-to-date, indicating that the new leadership may be steering the company towards a more positive trajectory.
See More
Acadia Healthcare to Release Q4 and Year-End 2025 Results
- Earnings Release Schedule: Acadia Healthcare announced it will release its Q4 and year-end 2025 results on February 25, 2026, before market open, reflecting the company's commitment to transparency and investor communication.
- Investor Conference Call: On the same day, Acadia will hold a conference call at 9:00 a.m. ET to engage with institutional investors and analysts, aiming to enhance market confidence.
- Network Coverage: As of September 30, 2025, Acadia operates 278 behavioral healthcare facilities across the U.S. and Puerto Rico, providing approximately 12,500 beds, showcasing its leadership in the industry.
- Employee and Patient Services: With around 25,500 employees serving over 82,000 patients daily, Acadia solidifies its position as the largest stand-alone behavioral healthcare company in the U.S.
See More
